Intellia Therapeutics, Inc.
Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
Last updated:
Abstract:
Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.
Status:
Application
Type:
Utility
Filling date:
24 Mar 2020
Issue date:
6 Aug 2020